KalVista Pharmaceuticals
KALV
KALV
76 hedge funds and large institutions have $153M invested in KalVista Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 14 closing their positions.
Holders
76
Holders Change
+1
Holders Change %
+1.33%
% of All Funds
1.67%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
15
Increased
21
Reduced
19
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
EAM
1
Eventide Asset Management
Boston,
Massachusetts
|
$19.5M |
2 |
2
Northern Trust
Chicago,
Illinois
|
$2.07M |
3 |
PAMU
3
Pictet Asset Management (UK)
London,
United Kingdom
|
$6.33M |
4 |
4
Squarepoint
New York
|
$1.44M |
5 |
O
5
OrbiMed
New York
|
$449K |